Concerns over reports of blood clots in a small number of recipients of the AstraZeneca COVID-19 vaccine prompted more than a dozen European countries to suspend use of the jab in recent days, even though the company and international health bodies said there was no indication that the vaccine was causing the clotting, and that inoculation should continue.